Tianjin Development (00882): Lisheng Pharmaceutical's net profit of 78.51 million yuan in the first three quarters decreased by 78.82% year-on-year

According to the Zhitong Finance App, Tianjin Development (00882) announced Lisheng Pharmaceutical's results for the nine months ended September 30, 2026, with total operating revenue of 888 million yuan, a year-on-year decrease of 11.84%; net profit attributable to owners of the parent company was 78.51 million yuan, a year-on-year decrease of 78.82%; and basic earnings per share were 0.25 yuan.